These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6463864)

  • 1. Specific active immunotherapy with butanol-extracted, tumor-associated antigens incorporated into liposomes.
    Steele G; Ravikumar T; Ross D; King V; Wilson RE; Dodson T
    Surgery; 1984 Aug; 96(2):352-9. PubMed ID: 6463864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of specific active immunization on tumor recurrence following primary tumor resection in WF rats with 1,2-dimethylhydrazine-induced bowel cancer.
    Ross DS; Steele G; Madara J; Lahey SJ; Ravikumar TS; Wilson RE; Munroe AE; Wright D; King VP
    J Natl Cancer Inst; 1984 Sep; 73(3):731-5. PubMed ID: 6590917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface antigens in a rat colon cancer model: correlation with inhibition of tumor growth.
    Steele G; Sjogren HO
    Surgery; 1977 Jul; 82(1):164-9. PubMed ID: 877853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial characterization of n-butanol-solubilized rejection-type antigens of syngeneic murine colon tumors.
    Sato N; Kikuchi K
    J Natl Cancer Inst; 1985 Apr; 74(4):883-8. PubMed ID: 3857382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin generation in experimental colon cancer of rats: effects of tumor growth and tumor therapy.
    Ravikumar T; Rodrick M; Steele G; Marrazo J; O'Dwyer P; Dodson T; King V
    J Natl Cancer Inst; 1985 Apr; 74(4):893-8. PubMed ID: 3872959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.
    Clary BM; Coveney EC; Philip R; Blazer DG; Morse M; Gilboa E; Lyerly HK
    Cancer Gene Ther; 1997; 4(2):97-104. PubMed ID: 9080118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
    Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
    Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The definitive value of active-specific immunotherapy for experimental carcinoma of the colon.
    Enker WE; Jacobitz JL
    Surgery; 1976 Aug; 80(2):164-70. PubMed ID: 941090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential extraction of tumor-specific transplantation antigen and embryonic antigen from simian virus 40- and adenovirus 7-induced sarcoma cells of hamsters with 1-butanol and 3 M potassium chloride.
    Coggin JH; Gillis LD; Payne WJ
    J Natl Cancer Inst; 1984 Apr; 72(4):853-62. PubMed ID: 6323810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraction of human organ-specific cancer neoantigens from cancer cells and plasma membranes with 1-butanol.
    Labateya N; Thomson DM; Durko M; Shenouda G; Robb L; Scanzano R
    Cancer Res; 1987 Feb; 47(4):1058-64. PubMed ID: 3100029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of tumor-associated antigens (TAA) in experimental immunotherapy.
    Ravikumar TS; Galbo L; Marini C; Kaplan P; Valmont I; Cunningham JN
    J Surg Res; 1986 Jun; 40(6):574-9. PubMed ID: 3747491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active immunization of hamsters against pancreatic carcinoma with lipid-treated cells or their shed antigens.
    Skornick Y; Kurman CC; Sindelar WF
    Cancer Res; 1984 Mar; 44(3):946-8. PubMed ID: 6692417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG generated against benign tumor-associated antigens prevented the effects of 1,2-dimethylhydrazine in rats.
    Zusman I; Zusman R; Karol D; Gurevich P
    Anticancer Res; 1996; 16(3A):1183-6. PubMed ID: 8702233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.
    van Broekhoven CL; Parish CR; Demangel C; Britton WJ; Altin JG
    Cancer Res; 2004 Jun; 64(12):4357-65. PubMed ID: 15205352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines.
    Rodolfo M; Zilocchi C; Melani C; Cappetti B; Arioli I; Parmiani G; Colombo MP
    J Immunol; 1996 Dec; 157(12):5536-42. PubMed ID: 8955204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of long-circulating immunoliposomes, directed against colon adenocarcinoma cells, by liver metastases of colon cancer.
    Kamps JA; Koning GA; Velinova MJ; Morselt HW; Wilkens M; Gorter A; Donga J; Scherphof GL
    J Drug Target; 2000; 8(4):235-45. PubMed ID: 11144234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunobiological and biochemical characterization of solubilized rat gliosarcoma cell tumor-associated transplantation antigens.
    Khoda H; Uede T; Yamaki T; Ibayashi Y; Sugawara H; Kikuchi K
    Jpn J Cancer Res; 1986 Aug; 77(8):833-42. PubMed ID: 2944861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor vaccination: where we stand.
    Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S
    Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of "tissue-type" specific immunotherapy on colon cancer recurrence in a minimal residual disease model.
    Harte PJ; Steele G; Rayner AA; Corson JM; Munroe AE; King VP; Wilson RE
    Curr Surg; 1982; 39(1):21-3. PubMed ID: 7060396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.